🧮 Stock Valuation Model: www.buymeacoffee.com/dividendtalks/extras ☕️ Feel free to buy me a coffee: www.buymeacoffee.com/DIVIDENDTALKS 📰 Join the FREE weekly Newsletter: dividendtalks.substack.com/subscribe Stock Tools I Use: 🚀 $30 OFF Seeking Alpha Premium: www.sahg6dtr.com/29N4DP9/R74QP 🚀 50% OFF TipRanks: www.tbg2jcftrk.com/262DXM/55M6S/ 💬 Join the community in our Discord: www.patreon.com/DividendTalks 👋 Follow me on X: www.x.com/DividendTalks Investing Platform I Use: 💰 Free shares up to £100 by joining Trading212: www.trading212.com/invite/Gux0x99S 🏆 Become a member to get access to to perks: ua-cam.com/channels/lLyc3C2K3C-RAh7eEJAwyg.htmljoin
First, I like your channel a lot. My non professional opinion on fair value for these: LMT: $426 COP: $84 LHX: $212 MSFT: $350 AMAT: $143 Value investors can buy high and make money if they hold great companies long enough but it is much better to buy when at fair or below fair value. This is my opinion. There are certainly securities reviewed by this channel that come in below fair value in my opinion and that is why I watch all episodes. The historical average of PE for S&P seems to be a bit under 20 and currently it looks to be around 30. I would love to own some of these at the right price.
Thank you for sharing your thoughts my friend. It is always great to hear everyone’s opinion. I agree the S&P 500 does look overvalued holistically and therefore we should be selective in what stocks we buy and spend more time analysing. One thing I would say though is that for high quality stocks like Microsoft, I don’t think it’s bad to dollar cost average into when they look reasonably valued rather than trying to time the market.
$PFE is much cheaper with plenty of upside for next year which made this past earning of $1.06 was a beat of .44 cent with a dividend of .42 which on a 1,000 shares of $420.00 each quarter and the CEO raise the outlook. In 12/21 was trading at $60.00 and under $30.00 is a steal being below half price which in the last month has 3 new FDA approve drugs with 30 drugs in Phase 3 trails and 40 in Phase 2 trails and about 40 in phase 1 trails. These number of different phases may not be correct , but being so much to remember , but I almost correct.
🧮 Stock Valuation Model: www.buymeacoffee.com/dividendtalks/extras
☕️ Feel free to buy me a coffee: www.buymeacoffee.com/DIVIDENDTALKS
📰 Join the FREE weekly Newsletter: dividendtalks.substack.com/subscribe
Stock Tools I Use:
🚀 $30 OFF Seeking Alpha Premium:
www.sahg6dtr.com/29N4DP9/R74QP
🚀 50% OFF TipRanks:
www.tbg2jcftrk.com/262DXM/55M6S/
💬 Join the community in our Discord: www.patreon.com/DividendTalks
👋 Follow me on X: www.x.com/DividendTalks
Investing Platform I Use:
💰 Free shares up to £100 by joining Trading212:
www.trading212.com/invite/Gux0x99S
🏆 Become a member to get access to to perks:
ua-cam.com/channels/lLyc3C2K3C-RAh7eEJAwyg.htmljoin
First, I like your channel a lot. My non professional opinion on fair value for these:
LMT: $426
COP: $84
LHX: $212
MSFT: $350
AMAT: $143
Value investors can buy high and make money if they hold great companies long enough but it is much better to buy when at fair or below fair value. This is my opinion. There are certainly securities reviewed by this channel that come in below fair value in my opinion and that is why I watch all episodes.
The historical average of PE for S&P seems to be a bit under 20 and currently it looks to be around 30. I would love to own some of these at the right price.
Thank you for sharing your thoughts my friend. It is always great to hear everyone’s opinion.
I agree the S&P 500 does look overvalued holistically and therefore we should be selective in what stocks we buy and spend more time analysing.
One thing I would say though is that for high quality stocks like Microsoft, I don’t think it’s bad to dollar cost average into when they look reasonably valued rather than trying to time the market.
AMAT seems intriguing
Long AMAT
$PFE is much cheaper with plenty of upside for next year which made this past earning of $1.06 was a beat of .44 cent with a dividend of .42 which on a 1,000 shares of $420.00 each quarter and the CEO raise the outlook. In 12/21 was trading at $60.00 and under $30.00 is a steal being below half price which in the last month has 3 new FDA approve drugs with 30 drugs in Phase
3 trails and 40 in Phase 2 trails and about 40 in phase 1 trails. These number of different phases may not be correct , but being so much to remember , but I almost correct.
Burry did some transactions like JD, BIDU and PDD. I am curious what you think about this stocks.
Might be a stupid question, but what website is it you use for the majority of the video? 2:01 for instance
Simply Safe Dividends 😊
Not a stupid question, keep asking questions.
great job as always my bro thank you
😊
🎉 ADVM 🎉
🎉 COEP🎉
🎉 PERI🎉
🎉PATH 🎉 😮😮😮😮😮
Microsoft 🎉🎉
Top pick stock for 2025 $tssi thank me later.
❤
Microsoft is still overvalued
Walgreens us undervalued
Hell no. Walgreens about to be a penny stock.